secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001564590-22-007614
Event type: other
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo settles patent disputes with BICO; receives $1.5M upfront and ongoing royalties
--------------------------------------------------------------------------------

- BICO will pay Organovo $1.5M upfront plus ongoing low-to-high single-digit % royalties on net sales of licensed products.
- All civil actions and IPR proceedings between the parties dismissed and terminated.
- BICO receives worldwide non-exclusive license to Organovo's foundational bioprinting patent portfolio.
- License covers all BICO brands and is perpetual until last patent expires; customary termination provisions included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022007614/0001564590-22-007614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000156459022007614/onvo-8k_20220222.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-007614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer